Miguel Martínez-Cava, autor en mAbxience

ARCHIVE

miguel.martinez

mAbxience and Abdi İbrahim Announce Landmark Technology Transfer Agreement, Advancing Biotechnology in Türkiye

Miguel Martínez-Cava2023-11-20T08:43:23+01:00November 20, 2023|

mAbxience and MS Pharma Sign Partnership for Denosumab Biosimilar in Select MEA Countries

Miguel Martínez-Cava2023-11-13T07:53:41+01:00November 13, 2023|

mAbxience and Abbott Sign Strategic Agreement to Broaden Access to a Pipeline of Biosimilars in Key Emerging Markets

Miguel Martínez-Cava2023-10-05T16:05:09+02:00September 20, 2023|